Houston Methodist Clear Lake Hospital, located in Nassau Bay, Texas, across from Johnson Space Center, is one of seven community hospitals that are part of Houston Methodist. It employs about 900 people, has an estimated 700 affiliated doctors and admits more than 5,700 patients annually.

During the past decade, Houston Methodist Saint John Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Houston Methodist Saint John Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator, "Eastern Cooperative Oncology Group" with 1 trials as a collaborator and "SWOG Cancer Research Network" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Houston Methodist Saint John Hospital" are "Invasive Breast Carcinoma" (2 trials), "Lung Non-Squamous Non-Small Cell Carcinoma" (2 trials), "Stage II Lung Cancer AJCC v8" (2 trials), "Stage IIIB Lung Cancer AJCC v8" (2 trials) and "ALK Gene Rearrangement" (1 trials). Many other conditions were trialed in "Houston Methodist Saint John Hospital" in a lesser frequency.

Most popular intervention types in "Houston Methodist Saint John Hospital" are "Other" (8 trials), "Drug" (7 trials), "Biological" (5 trials), "Procedure" (4 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Biospecimen Collection" (4 trials), "Carboplatin" (4 trials), "Pembrolizumab" (4 trials), "Quality-of-Life Assessment" (4 trials) and "Questionnaire Administration" (4 trials). Other intervention names were less common.

The vast majority of trials in "Houston Methodist Saint John Hospital" are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Houston Methodist Saint John Hospital". undefined are not yet recruiting, 7 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Houston Methodist Saint John Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Houston Methodist Saint John Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".